IMARC Group, Oct 2010, Pages: 234
worth more than US$ 167 Billion by 2015.
“Global Biopharmaceutical Market Report (2010-2015)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as
Transparency Market Research, July 2012
Biosimilars Market - Global And China Forecast, MarketShare, Size, Growth And Industry Analysis (2010-2017) Biosimilars or follow-on biologics are copies of biological drugs (biopharmaceuticals
China Research & Intelligence, March 2012, Pages: 50
ResearchReportonChinese Monoclonal AntibodyIndustry, 2012 "Antibody medicine is generally obtained from monoclonal antibody through genetic engineering, possessing the advantages of strong
JZMed Inc, Aug 2010, Pages: 299
industry between China and theUSTable 49. List of representative venture capital investors in China
Table 50. List of biotech companies in China focusing onstem cell research
Table 51. Comparison of stem
Research In China, Sep 2010, Pages: 121
Global and ChinaBiopharmaceuticalIndustryReport, 2010 In recent years, biopharmaceuticalindustry has been the fastest growing sector in the global pharmaceutical industry. From 1998 to 2009, the
Research In China, Sep 2010, Pages: 121
Global and ChinaBiopharmaceuticalIndustryReport, 2010 In recent years, biopharmaceuticalindustry has been the fastest growing sector in the global pharmaceutical industry. From 1998 to 2009, the
Industry Experts, April 2010, Pages: 240
Biopharmaceuticals is projected to reach US$182.5 billion, registering a CAGR of 12.4% during the period 2006-2015 by 2015. The report analyses the global and regional markets by all major product segments.
Intense
GBI Research, Dec 2009, Pages: 69
provides comprehensive information on the different service models present in the industry, key trends affecting contract research organizations and key analytical content on the market dynamics. The report
GBI Research, May 2011, Pages: 108
, IndiaandChina.
Reportisbuilt using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Technology Transfer
China Research & Intelligence, Dec 2010, Pages: 60
ResearchReportonChina's Animal Vaccine Industry - 2011-2012 The common animal vaccines at present are mainly applied in such mammals as pigs, cattle, sheep and bird species. In fact, fish and
GBI Research, Sep 2011, Pages: 114
insights into drivers, barriers and trends in the outsourcing of drug development tin the global pharmaceutical and biotechnology industry. The report profiles top 20 contract research organization in Asia
GBI Research, March 2011, Pages: 194
, primary and secondary research and in house analysis by GBI Research’s team of industry experts.
Scope
The report analyses the major trends in biopharmaceutical and medical devices market along with the
Research In China, July 2008 China Diagnostic ReagentMarketReport, 2007-2009 China's diagnostic reagent industry had lagged behind other countries for a long time. Since 1980s, China's reagent for clinical diagnosis has
Research In China, July 2008 China Diagnostic ReagentMarketReport, 2007-2009 China's diagnostic reagent industry had lagged behind other countries for a long time. Since 1980s, China's reagent for clinical diagnosis has
JZMed Inc, May 2011, Pages: 230
industry? What is the current state of the government’s regulation on product quality? Is drug formulation the next hot wave in the Chinese pharmaceutical industry?
- How will the Chinese formulation
Markets and Markets, Sep 2009, Pages: 189
biosimilars sector are expected to increase the market shares and profit margins while reducing medical expenditure.
Scope of the Report:
This report aims to identify and analyze biosimilars market on the
Research In China, Oct 2005, Pages: 80
China'sBiopharmaceuticalIndustry Study, 2005-2006 The report "China'sBiopharmaceuticalIndustry Study, 2005-2006" is classified into five parts, as follows:
1. Macro information onChina's
Business Insights, Aug 2007, Pages: 120
: Key opportunities and emerging therapies is a new report published by examining the current market and regulatory environment for biosimilars in Europe, India, China and theUS, whilst identifying the
Business Insights, March 2008, Pages: 165
trends and manufacturing strategies with this report’s analysis of the changing CMO industry structure, emerging business model capabilities and five year market growth forecasts.
- Discover the
Espicom Business Intelligence Ltd, July 2008, Pages: 204
Biopharmaceuticals in South East Asia Often overshadowed by commercial interest in China and India, the countries of SE Asia offer both a growing market for biopharmaceuticals and a research-driven
